Cytiva is expanding its Xcellerex X-platform portfolio with the addition of 500L and 2,000L bioreactors. Ludovic Brellier, President of Hardware Solutions, Cytiva, said: “Our customers need speed and flexibility to develop advanced therapeutics. The expansion of Cytiva’s Xcellerex X-platform portfolio and its additional features will help our customers scale their operations more efficiently. The design and functionality of the hardware, biocontainers, and software will allow our customers to...